share_log

双鹭药业(002038.SZ):利拉鲁肽处于三期整理数据阶段

Shuanglu Pharmaceutical (002038.SZ): Liraglutide is in the third phase of data collation

Gelonghui Finance ·  Sep 15, 2023 04:15

Gelonghui September 15?An investor asked Shuanglu Pharmaceutical (002038.SZ) on the investor interactive platform, "when will your company's Lilarutide be mass produced?" the company replied that Lilarutide is in the third phase of data processing.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment